Tuberculosis Costs in Spain and Related Factors

Gullón, José Antonio; García-García, José María; Villanueva, Manuel Ángel; Álvarez-Navascués, Fernando; Rodrigo, Teresa; Casals, Martí; Anibarro, Luis; García‐Clemente, Marta; Jiménez, María Ángeles Sánchez; Bustamante, Ana; Penas, Antón; Caminero, José A.; Caylà, Joan A.

doi:10.1016/j.arbr.2016.05.015

Cited by 4 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, the median length of hospital stay was 9 (interquartile range, 7 to 14) days, similar to results from a study in Spain (11.3 ± 7.0 days), 12 and lower than a study from the United States (19.5 days) that included pulmonary and EPTB patients. 13 Of the 810 patients, 5.94% were readmitted because of TB within 31 days after discharge.…”

Section: Discussionsupporting

confidence: 86%

Factors Associated with Extended Hospital Stay and its Impact on Subsequent Short-term Readmission with Tuberculosis Patients

Cao,

Xie,

et al. 2024

Arch Iran Med

View full text Add to dashboard Cite

<strong data-sider-select-id="72ab8072-c5c2-430e-955c-7d40b15e5789">Background: This study aimed to explore the factors associated with extended length of stay (LOSE) for patients with tuberculosis (TB) in China, and construct a nomogram to predict it. In addition, the impact of extended hospital stay on short-term readmission after discharge was assessed. <strong data-sider-select-id="fae5f176-d9ca-459d-b777-0c4860e05eec">Methods: A retrospective observational study was conducted at Changsha Central Hospital, from January 2018 to December 2020. Patients (≥18 years who were first admitted to hospital for TB treatment) with non-multidrug-resistant TB were selected using the World Health Organization’s International Classification of Diseases, 10th Revision (ICD-10-CM), and the hospital’s electronic medical record system. <strong data-sider-select-id="86fb3d7e-0f65-43d6-80be-478bfa46bbe2">Results: A multivariate logistic regression analysis was used to evaluate the associations between TB and LOSE. The relationship between length of hospital stay and readmission within 31 days after discharge was assessed using a univariate Cox proportional risk model. A total of 14259 patients were included in this study (13629 patients in the development group and 630 in the validation group). The factors associated with extended hospital stays were age, smear positivity, extrapulmonary involvement, surgery, transfer from other medical structures, smoking, chronic liver disease, and drug-induced hepatitis. There was no statistical significance in the 31-day readmission rate of TB between the LOSE and length of stay≤14 days groups (hazards ratio: 0.92, 95% CI: 0.80-1.06, P=0.229). <strong data-sider-select-id="a6f584f7-f578-408e-b36f-226653e345f6">Conclusion: LOSE with TB was influenced by several patient-level factors, which were combined to construct a nomograph. The established nomograph can help hospital administrator and clinicians to identify patients with TB requiring extended hospital stays, and more efficiently plan for treatment programs and resource needs.

show abstract

Section: Discussionsupporting

confidence: 86%

Factors Associated with Extended Hospital Stay and its Impact on Subsequent Short-term Readmission with Tuberculosis Patients

Cao,

Xie,

et al. 2024

Arch Iran Med

View full text Add to dashboard Cite

show abstract

“…FLOE et al [17] calculated the excess health-related costs of Danish TB patients and their spouses between 1998 and 2010 by matching 8433 patients with 337 070 controls and 3485 spouses with 17 403 controls, but did not include costs related to contact investigation procedures. Finally, GULLÓN et al [18], in their prospective study on 312 patients in Spain collected between September 2014 and September 2015, estimated the average cost per TB case at €10 262.62 but also included MDR-TB cases and assumed that the 2012 figure of €921.80 provided by DIEL et al [2] as an estimate for the per-patient cost of contact tracing would also apply to Spain, without performing their own calculations.…”

Section: Discussionmentioning

confidence: 99%

Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update

Diel

Nienhaus

2020

ERJ Open Res

View full text Add to dashboard Cite

BackgroundA total of 5429 new cases of tuberculosis (TB) were reported in Germany in 2018; out of the 3780 TB cases for whom drug susceptibility testing was available, the proportion of multidrug-resistant TB (MDR-TB) cases was only 3.1% (118 cases).MethodsOn the basis of the current therapy guidelines of the German Central Committee against Tuberculosis, this study estimates the mean direct outpatient and combined in- and outpatient costs per non-MDR-TB patient from the perspective of the German statutory health insurance (SHI) system, together with costs arising from productivity losses and costs due to public health screening for TB in close contacts.ResultsFrom the insurance perspective, the mean outpatient costs (rounded) per case were €1628 for adults and €1179 for children for standard therapy; the mean cost of inpatient treatment amounted to €8626. The mean combined inpatient/outpatient cost was €8756 for adults and €8512 for children. As 95% of all TB patients were adults, the weighted treatment cost per patient in Germany in 2018 was €8746. These are in addition to the mean cost arising from productivity losses (€1839) and, weighted by pulmonary infectivity, cost of contact investigations (€368), coming to a total of €10 953.ConclusionGiven the clear increase in the number of non-MDR-TB cases since 2015, TB is still a disease of significant economic impact in Germany.

show abstract

“…However, the effect of NRCMS was modest and the equity did not improve. Prior studies showed that age, household size, employment status, health insurance status, patient income as a percentage of total household income, hospitalization, and status as a minimum living security household are regarded as factors associated with the effect of NRCMS on TB patients' economic burden [13,14]. These studies paid further attention to the relations between TB patients' costs or benefits from medical insurance and their socio-demographic status.…”

Section: Introductionmentioning

confidence: 99%

What causes high costs for rural tuberculosis inpatients? Evidence from five counties in China

Cheng

Chen

2020

BMC Infect Dis

View full text Add to dashboard Cite

Background: Tuberculosis (TB) still causes high economic burden on patients in China, especially for rural patients. Our study aims to explore the risk factors associated with the high costs for TB inpatients in rural China from the aspects of inpatients' socio-demographic and institutional attributes. Methods: Generalized linear models were utilized to investigate the factors associated with TB inpatients' total costs and out-of-pocket (OOP) expenditures. Quantile regression (QR) models were applied to explore the effect of each factor across the different costs range and identify the risk factors of high costs. Results: TB inpatients with long length of stay and who receive hospitalization services cross provincially, in tertiary and specialized hospitals were likely to face high total costs and OOP expenditures. QR models showed that high total costs occurred in Dingyuan and Funan Counties, but they were not accompanied by high OOP expenditures. Conclusions: Early diagnosis, standard treatment and control of drug-resistant TB are still awaiting for more efforts from the government. TB inpatients should obtain medical services from appropriate hospitals. The diagnosis and treatment process of TB should be standardized across all designated medical institutions. Furthermore, the reimbursement policy for migrant workers who suffered from TB should be ameliorated.

show abstract

Tuberculosis Costs in Spain and Related Factors

Cited by 4 publications

References 13 publications

Factors Associated with Extended Hospital Stay and its Impact on Subsequent Short-term Readmission with Tuberculosis Patients

Factors Associated with Extended Hospital Stay and its Impact on Subsequent Short-term Readmission with Tuberculosis Patients

Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update

What causes high costs for rural tuberculosis inpatients? Evidence from five counties in China

Contact Info

Product

Resources

About